Upfront Advanced Radiotherapy and New Drugs for NSCLC Patients with Synchronous Brain Metastases: Is the Juice Worth the Squeeze? A Real-World Analysis from Lombardy, Italy

SIMPLE SUMMARY: This study aims to compare effectiveness and cost profile in non-small-cell lung cancer (NSCLC) patients harboring synchronous brain metastases (BMs) who received non-chemo first-line systemic therapy with or without advanced radiotherapy (aRT). A total of 177 lung cancer patients, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrao, Giulia, Franchi, Matteo, Zaffaroni, Mattia, Vincini, Maria Giulia, de Marinis, Filippo, Spaggiari, Lorenzo, Orecchia, Roberto, Marvaso, Giulia, Jereczek-Fossa, Barbara Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953825/
https://www.ncbi.nlm.nih.gov/pubmed/36831447
http://dx.doi.org/10.3390/cancers15041103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953825/
https://www.ncbi.nlm.nih.gov/pubmed/36831447
http://dx.doi.org/10.3390/cancers15041103

Ejemplares similares